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Abstract
Background: Bacterial persistence describes a phenomenon wherein a small subpopulation of cells is able to
survive a challenge with high doses of an antibiotic (or other stressor) better than the majority of the population.
Previous work has shown that cells that are in a dormant or slow-growing state are persistent to antibiotic
treatment and that populations with higher fractions of dormant cells exhibit higher levels of persistence. These
data suggest that a major determinant of the fraction of persisters within a population is the rate at which cells
enter and exit from dormancy. However, it is not known whether there are physiological changes in addition to
dormancy that influence persistence. Here, we use quantitative measurements of persister fractions in a set of
environmental isolates of E. coli together with a mathematical model of persister formation to test whether a single
general physiological change, such as cell dormancy, can explain the differences in persister phenotypes observed
in different strains.
Results: If a single physiological change (e.g. cell dormancy) underlies most persister phenotypes, then strains
should exhibit characteristic fractions of persister cells: some strains will consistently have high fractions of persisters
(dormant cells), whereas others will have low fractions. Although we found substantial variation in the fraction of
persisters between different environmental isolates of E. coli, these fractions were not correlated across antibiotics.
Some strains exhibited high persister fractions in one antibiotic, but low persister fractions in a second antibiotic.
Surprisingly, no correlation in persister fractions was observed between any two drugs, even for antibiotics with
nearly identical modes of action (ciprofloxacin and nalidixic acid).
Conclusions: These data support the hypothesis that there is no single physiological change that determines the
persistence level in a population of cells. Instead, the fraction of cells that survive antibiotic treatment (persist)
depends critically on the specific antibiotic that is used, suggesting that physiological changes in addition to
dormancy can underlie persister phenotypes.
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Background
Bacterial persistence is a form of phenotypic heteroge-
neity in which a subset of cells within an isogenic popu-
lation is able to survive challenges with antibiotics or
other stressors better than the bulk of the population [1].
The persistence phenotype is transient and non-genetic,
in contrast to antibiotic resistance, which is due to ge-
netic changes. However, the ability to form persister cells,
or the fraction of persister cells that are present in a cul-
ture, can be genetically controlled (see below). The
phenomenon of persistence has significant clinical rele-
vance [2], and it may be a primary factor as to why many
infections require long-course antibiotic treatment for
successful resolution [3]. Indeed, many patients with
chronic infections harbor pathogens with increased rates
of persister formation [4]. Thus, one of the most import-
ant questions concerning persister formation is deter-
mining the mechanisms that allow cells to become
physiologically recalcitrant to treatment with antibiotics
or other stressors.
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Recent work has suggested that persisters become
drug tolerant because they enter a dormant or slow-
growing state [5-9]. This dormant state is thought to
protect them from the lethal action of antimicrobials,
since many antibiotics interfere with proliferative pro-
cesses, such as cell wall assembly, DNA replication, or
protein synthesis [7,10].
Genetic studies in E. coli K12 have implicated several
genes that play a role in the rate of formation of both
dormant and persister cells. Many of these genes encode
toxin-antitoxin (TA) modules [7,8,11]. One example is
hipA (high persistence). One allele of this gene (hipA7)
causes a 100 to 1000-fold increase in persister levels
[12], and over-expression of hipA leads to growth arrest
and a persistence phenotype [13]. Several other loci have
also been associated. Maisonneuve et al. [11] recently
showed that overexpression of any one of five toxins
from mRNase TA pairs resulted in higher fractions of
persisters for both ciprofloxacin and ampicillin. In
addition, by serially deleting up to ten TA loci, the
authors showed that decreasing the number of TA loci
decreased the fraction of persisters. Deleting ten TA loci
decreased the persister fraction by 100-fold, from ap-
proximately 1% to 0.01% after five hours of antibiotic
treatment, and this decrease occurred for both ciproflo-
xacin and ampicillin. The authors proposed a model in
which mRNase toxins inhibit global translation, cells be-
come dormant, and thus persist. These data suggest that
in E. coli K12, a substantial fraction of persisters arise
through mechanisms involving mRNase TA loci (dele-
ting all ten loci results in a 99% reduction in persister
frequency; deleting any one locus results in only an ap-
proximately 10% reduction in persister frequency). It is
unknown whether similar mechanisms are important in
other bacteria.
Other than E. coli K12, the majority of persister studies
have focused on three bacterial taxa: Mycobacterium
tuberculosis, Pseudomonas aeruginosa, and Staphylococcus
aureus. M. tuberculosis is known for its recalcitrance to
antibiotic treatment [14-16], and genetic studies have
shown that toxin overexpression exhibits drug-specific
effects: toxins that increase persistence in one antibiotic do
not necessarily increase persistence in other antibiotics
[15]. This contrasts with results in E. coli K12 outlined
above, in which persistence is generally characterized by
multidrug tolerance [9,11]. In clinical settings, P. aeruginosa
mutants that produce increased persister fractions (up to
100-fold above wildtype) have been isolated [4]; however,
the genetic mechanisms causing increased persister frac-
tions are not well understood. Finally, in S. aureus, although
some research on the influence of metabolism on persister
formation [17], genetic studies are lacking.
Most studies on persister formation have focused on
strains harboring mutations that increase or decrease
persister frequency. However, one recent study [18] tested
how persister formation differs among strains of bacteria.
In this study, mammalian commensal and pathogenic
E. coli isolates were found to exhibit substantial variation
in the fraction of persisters that are present in exponen-
tially growing populations of cells. In addition, it was
found that the fraction of persisters that survived treat-
ment in one antibiotic was uncorrelated with the fraction
surviving in a second antibiotic. However, without a quan-
titative model of persistence, this result cannot unambi-
guously exclude other explanations, such as differences in
the death rates of cells between isolates.
Here, using a collection of environmental isolates of
E. coli, we examine variation in the frequency of persis-
ter cells in naturally occurring strains. In order to
consistently measure persister fractions, we use a ma-
thematical model to derive quantitative and reliable esti-
mates of the fraction of persisters in each population.
Our quantitative set of data corroborates the results of
the previous study on commensal and pathogenic E. coli
isolates [18], showing that there is substantial variation
in the fraction of persister cells among environmental
isolates of E. coli. In addition, we show that the fraction
of cells that survive drug treatment in one drug is uncor-
related with the fraction surviving in a second drug. Im-
portantly, we show that this lack of correlation extends
to drugs have nearly identical modes of action. Finally,
by using combinations of antibiotics, we provide evi-
dence that for any single strain, there may be a subset of
persister cells that are recalcitrant to treatment with any
antibiotic. In particular, although treatment with differ-
ent antibiotics results in different fractions of persister
cells for any one strain, treating that strain with combi-
nations of antibiotics frequently selects for the subset
of cells that persists in the face of the most harmful
antibiotic.
Together, these data imply that the ability of cells to per-
sist in the face of antibiotic treatment depends on the spe-
cific mechanism by which the persister phenotype is
generated, and the precise manner in which the antibiotic
acts: cells that persist in one antibiotic may not persist in a
second antibiotic, even if that antibiotic has a very similar
mode of action. These data contrast strongly with data
from experimental studies on lab strains of E. coli, which
have generally shown that when mutants exhibit higher
levels of persistence in one antibiotic, they also exhibit
higher levels of persistence in other antibiotics (multidrug
tolerance) [6,7,11,13,19-22]. However, there do appear to
be a subset of cells that persist after treatment with mul-
tiple antibiotics, as evidenced by using combination treat-
ments. Finally, the data here suggest that the parameter
that has the largest influence on the fraction of persisters
exhibited by any strain is the rate of switching from a nor-
mal cellular phenotype to a persister state; in contrast, the
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rate of switching from persister to normal cell has a much
smaller influence.
Results
Consistent quantification of persister fractions
A critical issue when studying bacterial persistence is the
precise definition of the persister fraction. Previous studies
have defined persister cells as the surviving fraction after
antibiotic exposure for an arbitrary amount of time, ran-
ging from hours [4,8,10,11,19,23-25] up to several days
[15]. In addition, these fractions have been assessed at dif-
ferent growth states: mid-exponential [8,10,11,19,25], late
exponential [24] and in rare cases, stationary phase
[4,24,25]. Most often, these studies are performed in liquid
cultures of rich media. However, some studies have
assayed persisters on agar [6,12,13], by plating samples of
logarithmically growing cultures on LB agar with ampicil-
lin, incubating overnight, spraying the plates with penicil-
linase, and again incubating for 24 hours to count the
number of surviving cells. These different methods tre-
mendously complicate comparisons across studies.
To quantify the fraction of persisters in a consistent
manner, we use a model motivated by observations of
persister cell dynamics first reported by Balaban et al. [6],
who observed two types of persister cells, which they pro-
posed arose through two different mechanisms. Type I
persisters occurred through unspecified events that occur
during stationary phase, and remained fully dormant until
switching to a normal growth state. These have been asso-
ciated with a specific genotype, the hipA7 allele. Type II
persisters arise through an infrequent stochastic switch to
a slow-growth state, and remain so until switching to a
normal growth state. These were associated with a muta-
tion at a second locus, hipQ. A similar model of persister
formation has been proposed by Wiuff et al. [23].
Here we apply this simple two-state model assuming
simplified type II persister dynamics. In this model, cells
exist in two states, normal and persister. During antibiotic
treatment, normal cells die at a rate μ and switch to a pers-
ister state at rate α. Persister cells do not die or grow, and
switch to a normal state at rate β (see Additional file 1).
The advantage of using a this model is that the parameters
that we infer, such as the fraction of persister cells, do not
depend on experimental idiosyncrasies, for example, the
time at which cell numbers are measured. It has been diffi-
cult to compare the results of many previous experiments
on persisters for this reason.
Persister fractions differ between environmental isolates
We selected 11 E. coli isolates from a collection of more
than 450 environmental isolates sampled over a period
of 12 months from two sites approximately 2m apart
near a watershed of Lake Superior (46°42'04'N, and 92°
12'26'W) [26]. Despite the nearly identical geographical
provenance of these isolates, partial genomic sequencing
of a subset of these 450 strains has shown that while all
are Escherichia species, they encompass a genetic diver-
sity greater than the standard panel of E. coli strain di-
versity, the ECOR collection. This initial genomic data
show that isolates from this location are spread across
the E. coli phylogeny, with members in clades A, B1, B2,
D, E, F, and C-V [27] (Bertels et al., in prep). Although
the strains in this collection harbor considerable genetic
diversity, for the most part, they are not pathogenic,
typing negatively for most common virulence loci
(M. Sadowsky, personal communication).
We selected the subset of 11 environmental isolates
on the basis of their differential levels of survival in
ampicillin after 24 hours of treatment (using CFU
counts; see Methods). In doing so, we aimed to find
strains that differed to the greatest extent in the fraction
of persisters that were formed in ampicillin, such that
we would have the greatest power to discern whether
these differences were paralleled in other antibiotics. In
addition to these isolates, we used the standard labora-
tory strain E. coli K12 MG1655, for a total of 12 strains
in which we quantified persister fractions.
For each of these strains, we first determined the MIC
for ampicillin (see Methods), and found that the MICs
for these strains differed by less than two-fold (Additional
file 2: Table S1). This suggested that the differences in sur-
vival did not arise simply from differences in growth and
killing dynamics, and may instead have resulted from dif-
ferences in persister formation.
We then quantified, for each strain, survival curves over
48 hours during treatment with 100 mg/ml of ampicillin
(Figure 1). In the vast majority of cases, the curves that we
observed were clearly not characterized by a single expo-
nential decrease, as would be expected if all individuals in
the population had equal susceptibility to the antibiotic.
This suggested that at least two distinct populations of
cells were present. We denote these subpopulations as
normal and persister cells. We used these survival curves
in conjunction with a mathematical model of persistence
to quantify the persister fraction for each strain. In this
model we fit four independent parameters (see Additional
file 1) to infer the rate of death of normal cells, the rates of
switching between normal and persister states, and the
fraction of persisters. For each strain, we used at least five
biological replicates for model fitting.
Using this method, we found that the fraction of persis-
ters differed significantly between strains, from less than
0.001% to more than 10% (Figures 1 and 2; Additional
file 3: Table S2), a range of over four orders of magnitude.
Persister fractions in different antibiotics are uncorrelated
To infer persister fractions, we also measured kill curves
for each strain in two additional antibiotics, ciprofloxacin
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and nalidixic acid, both belonging to the quinolone class
of antibiotics [28]. By selecting two antibiotics in the
same class, we aimed to test whether persister fractions
were similar and consistent for drugs with comparable
modes of action. We first measured the MICs of these
12 strains in both antibiotics, and found that the MIC
values showed little variation (differing by 2.5-fold and
3.5-fold for ciprofloxacin and nalidixic acid, respectively;
Additional file 2: Table S1). We used the same method
outlined above to quantify the persister fractions in these
antibiotics. We again found substantial variation in the
persister fractions, ranging from 0.001% to 0.15% in cipro-
floxacin, and from less than 0.001% to more than 1% in
nalidixic acid (Additional file 3: Tables S2).
Our hypothesis is that for each strain, persisters are
generated through a single general mechanism, such as
cell dormancy, and that this mechanism confers a multi-
drug tolerance. If this is true, then strains should exhibit
characteristic persister fractions: we expect that for some
isolates this subset of cells will be large, and thus these
isolates will have high fractions of persisters across all
antibiotics, while for other isolates, this subset of cells
will be small, resulting in a small fraction of persisters
across all antibiotics. This pattern has been shown pre-
viously for the hipA7 mutant of E. coli K12, after relE
overexpression in K12, or after deletion of TA-pairs
[11,29,30]. In all of these cases, these genetic changes
caused a general increase in the fraction of persisters
across several classes of antibiotics.
We tested this hypothesis by looking for positive corre-
lations in the fraction of persisters in the three antibiotics
(ampicillin, ciprofloxacin, and nalidixic acid). However,
despite the considerable variation in the persister fractions
found among isolates (Figure 2), no consistent positive
correlations were found (rho = -0.49, p = 0.46, N = 12 for
ampicillin versus ciprofloxacin, rho = 0.55, p = 0.07, N = 12
for ampicillin versus nalidixic acid, rho = −0.30, p = 0.34,
N = 12 for ciprofloxacin versus nalidixic acid, Spearman
correlation; Figure 3). Importantly, we found no positive
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Figure 1 Environmental isolates exhibit substantial variation in
persister fractions after treatment with 100 ug ampicillin. The
kill curves are characterized by biphasic behavior, implying that
there are at least two distinct populations of cells with differing
death rates. The plot shows the killing data of six replicate cultures
for three strains (SC552, SC649 and MG1655); the lines indicate the
best-fit models for each replicate.
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Figure 2 Environmental isolates exhibit different fractions of persisters after treatment with ciprofloxacin or nalidixic acid. The plots
show six replicates for each of the three strains shown in Figure 1. A: Killing dynamics during 48 hours of treatment with ciprofloxacin. Biphasic
dynamics, similar to those observed in Figure 1, are observed. B: Killing dynamics during 48 hours of treatment with nalidixic acid. There are large
differences in persister fractions between the two antibiotics, with strain SC649 exhibiting a low fraction of persisters in ciprofloxacin, but a high
fraction in nalidixic acid.
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correlation between the persister fractions in ciprofloxacin
and nalidixic acid, although these two antibiotics have very
similar mechanisms of action, with both targeting the DNA
gyrase subunits gyrA and gyrB and the topoisomerase IV
subunits parC and parE [31,32]. It is unlikely that this re-
sult is due to an inability to accurately measure the persister
fractions, as independent measurements yielded highly con-
sistent values (Figures 1 and 2). Thus, this result suggests
that different types of persister cells exist within popula-
tions, some of which are persistent to one antibiotic, while
others are persistent to other antibiotics. In addition, this
shows that E. coli persister cells are not necessarily charac-
terized by multidrug tolerance. Although this contrasts with
previous observations for mutants of E. coli K12, it is in
concordance with observations in M. tuberculosis [15].
Evidence that a subset of persister cells is multidrug
tolerant
We selected two strains on the basis of the persister
fractions that they exhibited in single antibiotics, requir-
ing that the strains exhibit a high level of persistence in
at least one antibiotic. For these two strains we re-
measured the persister fractions in single antibiotics, as
well as in all pairwise combinations of the three antibio-
tics. We found that the killing dynamics were qualita-
tively similar to those when using a single antibiotic: all
kill curves exhibited biphasic behavior, indicating that at
least two subpopulations of cells were present (Figure 4).
The precise dynamics of this killing in combinations of
antibiotics may yield additional insight into how persisters
are formed. We briefly outline three general possibilities.
(1) No cells persist when a population is simultaneously
treated with antibiotics. This implies that the mechanisms
underlying persistence to the two antibiotics are exclusive,
and cannot occur within the same cell. (2) The fraction
of persistent cells under the combination of antibiotics
is approximately multiplicative relative to the fraction
in the two single antibiotics. Although this observation
would be consistent with several explanations, the sim-
plest is that the mechanisms of persister formation are
independently induced, and occur randomly within the
same cell. (3) The fraction of persistent cells under a
combination of antibiotics is similar to the fraction
observed under treatment with the more lethal anti-
biotic. Again, although several explanations would be
consistent with this, the simplest is that cells that are
persistent to the more lethal antibiotic are also persist-
ent to the second. We refer to these three hypotheses as
exclusive, independent, and coincident, respectively.
We found that for these two strains, there were no
cases in which persister fractions were exclusive. Instead,
the persister populations were largely coincident, with
the fraction of cells in combinations of antibiotics being
similar to the fraction observed in the more lethal anti-
biotic (Figures 4 and 5). This is consistent with this sub-
set of cells being multidrug tolerant. Thus, although not
all persisters are multi-drug tolerant, there appears to be
a subset that is.
Toxin-antitoxin pairs are frequently gained and lost in
E. coli isolates
One possible explanation for the differences in persister
formation of environmental isolates is that the activation of
different toxin-antitoxin pairs results in different antibiotic
susceptibilities. To further examine this hypothesis, we
looked at the presence of TA loci that are known to affect
persister formation in 15 E. coli and Shigella taxa, as well
as in Escherichia fergusonii. We found significant variation
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Figure 3 No correlation is observed between persister fractions in different antibiotics. We found that although the calculated persister
fractions are repeatable, there is no consistent correlation between the fractions of persisters in any two antibiotics. The plots show the
correlations in persister fractions. A: ampicillin and ciprofloxacin; B: ampicillin and nalidixic acid; and C: ciprofloxacin and nalidixic acid. Only one
strain exhibits a very high fraction of persisters in two antibiotics; however, these antibiotics are ciprofloxacin and ampicillin, members of two
different classes. The error bars indicate standard errors for the biological replicates. The values of Spearman’s rho and the corresponding p-value
are shown in each plot.
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in the presence of TA modules across different E. coli iso-
lates (Figure 6), suggesting that these loci are lost (and/or
gained) over relatively short time scales in this clade. Such
changes in the number or types of TA pairs are likely to
affect the production of persister cells, as has been shown
experimentally [11].
The rate of switching from normal to persister state is the
primary determinant of persister fractions
In the analyses above, we have used information from cell-
killing dynamics to infer the proportion of persister cells
that were present at the start of antibiotic killing. These
persisters are formed during exponential growth, and the
fraction that is present is determined largely by two inde-
pendent parameters, the rates of switching to and from
the persister cell state. To gain additional insight into the
mechanistic underpinnings of persister formation, we
examined the relationship between the persister fraction
and these two parameters. We find strong evidence that
the primary determinant of the persister fraction is the
rate at which persister cells are formed from normal cells:
these two variables are strongly correlated across both
strains and antibiotics (Figure 7). In contrast, the rate of
switching from persister to normal cell has little to no re-
lationship with the persister fraction.
Discussion
In generating antibiotic kill curves from CFU data, we
have shown that these curves differ substantially between
environmental isolates of E. coli for single antibiotics. In
addition, we found that the shape of these curves differs
between different antibiotics. Using a quantitative theore-
tical model of the relationship between the shape of these
curves and persister formation, we have been able to show
that these results imply that persister fractions differ be-
tween environmental isolates and between antibiotics.
Our results imply that there are no E. coli strains that have
generally high or low levels of persisters; instead, there are
different types of persister cells within populations, and
each type may be more or less persistent to different anti-
biotics. Importantly, the variation in persister fractions
exists even for antibiotics with nearly identical modes of
action (ciprofloxacin and nalidixic acid). Mechanistically,
this suggests that persistence through cell dormancy is not
a single, general phenomenon. Instead, there may be dis-
tinct physiological states of dormancy, each of which is
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differently susceptible to a particular antibiotic. The idea
that there are different types of persister cells that arise
from a variety of mechanisms has also been proposed in a
recently published study [34].
We note that one complicating factor in this interpre-
tation is that these different persister populations may
have different propensities to form colonies, and that
this might explain some of the differences in the shapes
of the kill curves that we observed. However, given the
range of persister fractions that we observed (over four
orders of magnitude), we do not think that this mecha-
nism can fully explain the patterns that we find.
It is also possible that although the isolates that we
studied have similar MIC values, they differ in their
pharmacodynamics [35]. However, the persister fraction
should largely be independent of the pharmacodynamic
behavior; thus this is unlikely to account for the differ-
ences that we observe between isolates [34].
Evidence of two different types of persister cells has
been shown previously by Balaban et al. [6], and genotypic
changes at different loci were associated with each pheno-
type. Similarly, genetic differences between different E. coli
isolates, such as the presence or absence of TA various
modules, may affect the production of persister cells
(Figure 6).
Gefen et al. [36] suggested that large differences in the
measurement of persister fractions might arise because
antibiotic exposure begins at different stages of exponen-
tial growth (before or after 1.5 hours of growth). How-
ever, by growing the cells for four hours, we hope to
have minimized such effects, and propose that the large
differences we find in persister fractions are not due to
differences in growth stage, but to fundamental differ-
ences in the mechanisms of persister production.
We note that the set of environment isolates that we
have used are not known to be pathogenic, suggesting
that many of them have had less exposure to antibiotics
and the concomitant selection for resistant or persister
phenotypes that arises from such exposure. In previous
studies of clinical isolates, selection has been shown to
result in rapid changes in the frequency of genotypes dif-
fering in their ability to form persisters [4]). However,
our results suggest that even in the absence of recent
bouts of antibiotic-mediated selection, we find that
Amp Cip Amp+Cip
P
er
si
st
er
 fr
ac
tio
n
1e
−
07
1e
−
05
1e
−
03
1e
−
01
Amp Nal Amp+Nal
SC552
antibiotic
1e
−
07
1e
−
05
1e
−
03
1e
−
01
Cip Nal Cip+Nal1e
−
07
1e
−
05
1e
−
03
1e
−
01
Amp Cip Amp+Cip
P
er
si
st
er
 fr
ac
tio
n
1e
−
07
1e
−
05
1e
−
03
1e
−
01
Amp Nal Amp+Nal
SC649
antibiotic
1e
−
07
1e
−
05
1e
−
03
1e
−
01
Cip Nal Cip+Nal1e
−
07
1e
−
05
1e
−
03
1e
−
01
A B C
D E F
Figure 5 A subset of persister cells is multidrug tolerant. The persister fractions estimated from the killing dynamics are shown for single
or combinations of antibiotics. A: strain SC552; B: SC649. For both strains, there is a subset of persisters that appear to be resistant to
both antibiotics.
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persister fractions differ considerably among different ge-
notypes, suggesting that variation in persister-forming
ability is harbored naturally in populations.
Previous studies have indirectly implied that mecha-
nisms of persister formation may differ between strains
for different antibiotics. Keren et al. [7] showed that one
strain of E. coli K12 (AT984 dapA zde-264::Tn10) exhi-
bited a higher fraction of persisters in ofloxacin com-
pared to ampicillin, whereas Spoering et al. [24] showed
the reverse: E. coli K12 wildtype exhibits a lower fraction
of persisters in ofloxacin than ampicillin. For both stu-
dies, the drugs were used at identical concentrations
(5 ug/ml and 100 ug/ml, respectively). Again, this result
suggests that even for E. coli K12, closely related mutants
do not necessarily produce large or small persister frac-
tions, but these fractions depend specifically on the type
of antibiotic and strain used.
To our knowledge, the effect of pairwise combinations
of antibiotics has not been investigated with respect to
bacterial persistence. We found that the killing dynamics
under combinations was qualitatively similar to that
observed under a single antibiotic, with biphasic kill
curves. Furthermore, the observation of co-incident per-
sister fractions provide evidence that there is a small num-
ber of persister cells that exhibit multidrug resistance, and
are thus persistent to all combinations of antibiotics
(Figure 5). However, the majority of persister cells do not
exhibit multidrug-resistance.
Conclusions
The results of our study clearly show that the fraction of
persisters within an isogenic culture is highly dependent
on the antimicrobial compound and the bacterial strain.
Importantly, differences in persister fractions exist even
for antibiotics of the same class. This contrasts markedly
with the majority of laboratory studies of E. coli K12,
which have generally found that persister phenotypes are
characterized by multi drug tolerance. These results
complicate the search for persister mechanisms, since
even within the same strain different types of persister
cells exist, with none clearly dominating.
Figure 6 Known persister loci are rapidly gained and/or lost
within the E. coli clade. Grey boxes indicate the presence of the
orthologue in the indicated genome; white indicates absence. The
data suggests that toxin – antitoxin loci undergo rapid loss and/or
gain within the E. coli clade. Orthologue presence – absence of
toxin-antitoxin loci is based on a bidirectional best-hit analyses [33]
for 14 E. coli and Shigella taxa and E. fergusonii.
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Figure 7 The primary determinant of the persister fraction is the rate of switching to the persister state. A: The rate of switching from
the normal cellular state to the persister state is strongly correlated with the fraction of persisters in the population. B: There is little to no
correlation between the rate of switching from the persister state to the normal state and the fraction of persisters. C: No correlation exists
between the rate of death of normal cells and the persister fraction.
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Methods
Strains
The E. coli natural isolates used in this study were selected
from a collection of 456 E. coli sampled from a watershed
of Lake Superior, Minnesota, USA (46°42'04'N, and 92°
12'26'W [26]; Additional file 2: Table S1). For this study,
all strains were treated with ampicillin (100 μg/ml) for
24 h, and 11 strains that showed marked differences in
survival (as measured by colony counts) were selected.
Media
M9 salts supplemented with 0.2% glucose was used as a
growth medium in all experiments.
Determination of minimum inhibitory concentrations
(MICs)
Single colonies were used to inoculate 200 μl of M9 salts
supplemented with 0.2% glucose in 96-well plates. The
plates were incubated overnight at 37°C with shaking at
400 rpm. These overnight cultures were diluted 1:100 into
fresh medium and incubated for 2 h at 37°C with shaking
at 400 rpm to ensure logarithmic growth. Approximately
5 × 107 cells were then used to inoculate 150 μl of M9 con-
taining different concentrations of antibiotics and all wells
were covered with 50 μl mineral oil to avoid evaporation.
Growth was assessed by measuring the optical density
(OD) at a wavelength of 600 nm over 20 hours using a
plate-reader system from BioTek. The lowest concentration
of antibiotic that did not exceed an OD of 0.01was taken to
be the MIC of that antibiotic for a particular strain.
Antibiotic kill curves
Single colonies were used to inoculate 200 μl M9 mi-
nimal medium supplemented with 0.2% Glucose. The
plates were incubated overnight at 37°C with shaking at
400 rpm. The overnight culture was diluted 1:100 into
1.5 ml fresh medium in a 24-well plate and incubated at
37°C with shaking at 250 rpm for 4 h to ensure logarith-
mic growth of the cultures. After 4 h of incubation,
antibiotics were added at the following concentrations:
100 μg/ml ampicillin, 0.1 μg/ml ciprofloxacin and 150 μg/ml
nalidixic acid. In preliminary experiments using kanamy-
cin, we found that regrowth frequently occurred, despite a
secondary spiking of the culture with kanamycin. This
suggested that resistance often arose [37], and we did not
pursue this drug further. After the addition of the antibio-
tics, hourly samples were taken for the first 4 h, serially
diluted in phosphate buffered saline (PBS) and spot-plated
in 5 μl drops onto LB agar plates to determine colony-
forming units (CFU). Additional samples were taken at 20,
24, 28 and 48 hours (with slight variations) after addition
of the antibiotic and 100 μl–500 μl were plated to LB agar
plates, depending on the counts of previous time points.
All assays were performed using 6 replicates and all plates
were counted at least twice on different days (after 24 and
48 hours) to ensure the detection of late appearing col-
onies [38]. Surviving colonies were tested for resistance to
the respective drug they were treated with and replicates
with resistant cells were excluded from the analysis. For
the three antibiotics in which we present data on here
(nalidixic acid, ampicillin, and ciprofloxacin), resistance
was rarely observed, and only with ciprofloxacin and nali-
dixic acid.
For a subset of cases, we repeated the kill curve mea-
surements using colonies that survived 48 hours of anti-
biotic treatment. In all cases, we observed dynamics
similar to those observed for the original culture (data
not shown), showing that these cells are likely to differ
only in a phenotypic, and not genotypic, manner. In
addition, we spiked the cultures with additional anti-
biotic after 24 hours, and found that this had no signifi-
cant effect on the killing dynamics, showing that the
dynamics we observe are not due to degradation of the
antibiotic. Assays using combinations of antibiotics were
performed similarly to those outlined above, with the
antibiotics added at the same concentrations as they
were in the single-drug assays. In this case, the experi-
ments were performed in duplicate.
Quantification of persister fractions
The fraction of persisters, death rates and switching
rates between persister and normal states were calcu-
lated using a model motivated by Balaban et al. [6]. In
this model, cells switch between two states, normal and
persister. The equations describing the dynamics of this
switching is detailed in the Additional file 1, together
with the exact solutions of these coupled differential
equations.
We used maximum likelihood to fit the CFU count
data, under the assumption that the error in the CFU
counts results primarily from Poisson sampling, using
the likelihood function:
Λðc1; c2; λ1; λ2jxÞ ¼
Yt¼T
t¼0
N tjc1;c2;λ1;λ2ð Þ
δt
 xt
xt !
 exp N tjc1; c2; λ1; λ2ð Þ
δt
 
in which xt is the number of CFUs observed at time
point t, δt is the dilution at time point t, and N(t) is the
number of cells predicted by the model (see Additional
file 4). The values that these parameters can take are
restricted, as outlined in the Additional file 1.
Likelihood maximization was done using optim() in the
R statistical framework [39]. Likelihood convergence was
checked by using ten separate starting values for the para-
meters and three optimization algorithms, Nelder-Mead,
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SANN, and BFGS. The values of the a, b, m, and F0 (the
initial fraction of persisters) were determined independ-
ently for each replicate, and we calculated confidence
intervals assuming normally distributed error. Because the
values of a, b, and m cannot be uniquely fit (see Additional
file 1), we calculated them using the median value of F0; in
most cases, the uncertainty in F0 is very low, with most
minimum and maximum values of F0 ranging between
0.99 and 1. Thus, this approximation has little effect on
our data.
All other statistical analyses were performed using R [39].
Additional files
Additional file 1: Appendix.
Additional file 2: Table S1. Minimum inhibitory antibiotic
concentrations for each strain. The MICs ranged between 15-22.5 μg/ml
for ampicillin, between 0.008-0.030 μg/ml for ciprofloxacin and 3-7.5 μg/
ml for nalidixic acid. This variation in MICs was considerably smaller than
the variation in persister fractions exhibited by the selected strains and
moreover, the fraction of persisters and their corresponding MICs
showed no correlation, suggesting that the variation in MICs does not
account for the one observed in the level of persister cells. No resistance
to the three used antibiotics was evident for any of the examined.
Additional file 3: Table S2. Estimated death rates and switching rates
for all strains in the three antibiotics (ampicillin, ciprofloxacin, and
nalidixic acid). The parameters are explained in the Additional file 1.
Electronic supplementary material.
Additional file 4: R code for maximum likelihood fitting. The R code
used to perform the fits of the data is provided.
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